Search

Your search keyword '"Bewley, Kevin"' showing total 156 results

Search Constraints

Start Over You searched for: Author "Bewley, Kevin" Remove constraint Author: "Bewley, Kevin"
156 results on '"Bewley, Kevin"'

Search Results

1. Quantification of SARS-CoV-2 neutralizing antibody by wild-type plaque reduction neutralization, microneutralization and pseudotyped virus neutralization assays

3. Detection of SARS-CoV-2 BA.2.86 by lateral flow devices

4. The identification of immune-reactive proteins recognised in response to Coxiella burnetii infection

5. Comparison of rhesus and cynomolgus macaques as an infection model for COVID-19

6. ChAdOx1 nCoV-19 protection against SARS-CoV-2 in rhesus macaque and ferret challenge models

7. Dose-dependent response to infection with SARS-CoV-2 in the ferret model and evidence of protective immunity

9. Evaluation of the neutralising antibody response in human and hamster sera against SARS-CoV-2 variants up to and including BA.2.86 using an authentic virus neutralisation assay

11. Detection of SARS-CoV-2 BA.2.86 by lateral flow devices

12. The Omicron Sub-Variant BA.4 Displays a Remarkable Lack of Clinical Signs in a Golden Syrian Hamster Model of SARS-CoV-2 Infection

13. Immunisation with purified Coxiella burnetii phase I lipopolysaccharide confers partial protection in mice independently of co-administered adenovirus vectored vaccines

14. Syrian hamster convalescence from prototype SARS-CoV-2 confers measurable protection against the attenuated disease caused by the Omicron variant

15. SARS-CoV-2 Disease Severity in the Golden Syrian Hamster Model of Infection Is Related to the Volume of Intranasal Inoculum

16. Assessment of the Biological Impact of SARS-CoV-2 Genetic Variation Using an Authentic Virus Neutralisation Assay with Convalescent Plasma, Vaccinee Sera, and Standard Reagents

17. Influence of Aerosol Delivered BCG Vaccination on Immunological and Disease Parameters Following SARS-CoV-2 Challenge in Rhesus Macaques

18. Convalescence from prototype SARS-CoV-2 protects Syrian hamsters from disease caused by the Omicron variant

20. mRNA vaccination in people over 80 years of age induces strong humoral immune responses against SARS-CoV-2 with cross neutralization of P.1 Brazilian variant

21. Dose-dependent response to infection with Ebola virus in the ferret model and evidence of viral evolution in the eye.

22. Author response: mRNA vaccination in people over 80 years of age induces strong humoral immune responses against SARS-CoV-2 with cross neutralization of P.1 Brazilian variant

23. Immunological and pathological outcomes of SARS-CoV-2 challenge following formalin-inactivated vaccine in ferrets and rhesus macaques

24. T cell and antibody responses induced by a single dose of ChAdOx1 nCoV-19 (AZD1222) vaccine in a phase 1/2 clinical trial

25. Evidence of escape of SARS-CoV-2 variant B.1.351 from natural and vaccine-induced sera

26. Reduced neutralization of SARS-CoV-2 B.1.1.7 variant by convalescent and vaccine sera

27. Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials

28. Intranasal Infection of Ferrets with SARS-CoV-2 as a Model for Asymptomatic Human Infection

29. ChAdOx1 nCoV-19 protection against SARS-CoV-2 in rhesus macaque and ferret challenge models

30. BNT162b2 Vaccination in People Over 80 Years of Age Induces Strong Humoral Immune Responses with Cross Neutralisation of P.1 Brazilian Variant

31. Reduced Neutralization of SARS-CoV-2 B.1.1.7 Variant from Naturally Acquired and Vaccine Induced Antibody Immunity

32. Prophylactic intranasal administration of a TLR2/6 agonist reduces upper respiratory tract viral shedding in a SARS-CoV-2 challenge ferret model

33. Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK

34. Immunological and pathological outcomes of SARS-CoV-2 challenge after formalin-inactivated vaccine immunisation of ferrets and rhesus macaques

35. Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial

36. Amplicon-Based Detection and Sequencing of SARS-CoV-2 in Nasopharyngeal Swabs from Patients With COVID-19 and Identification of Deletions in the Viral Genome That Encode Proteins Involved in Interferon Antagonism

37. Prophylactic intranasal administration of a TLR2 agonist reduces upper respiratory tract viral shedding in a SARS-CoV-2 challenge ferret model

38. Comparison of Rhesus and Cynomolgus macaques as an authentic model for COVID-19

39. Neutralization of SARS-CoV-2 by Destruction of the Prefusion Spike

40. Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial

41. Dose-dependent response to infection with SARS-CoV-2 in the ferret model: evidence of protection to re-challenge

42. Amplicon based MinION sequencing of SARS-CoV-2 and metagenomic characterisation of nasopharyngeal swabs from patients with COVID-19

43. Nosocomial buffalopoxvirus infection, Karachi, Pakistan

44. A black necrotic ulcer. (Case report)

46. Animal Models of Q Fever (Coxiella burnetii)

47. Antiviral Screening of Multiple Compounds against Ebola Virus

48. Chloroquine inhibited Ebola virus replication in vitro but failed to protect against infection and disease in the in vivo guinea pig model

49. Dengue virus serotype 3, Karachi, Pakistan

50. Assessment of the Protective Effect of Imvamune and Acam2000 Vaccines against Aerosolized Monkeypox Virus in Cynomolgus Macaques

Catalog

Books, media, physical & digital resources